doi: 10.1080/21688370.2016.1176822 Summary Keywords glucagon-like peptide-1 receptor agonist (GLP-1RA), oral, subcutaneous, semaglutide, type 2 diabetes, safety Citation Smits MM and Van Raalte DH (2021) Safety of Semaglutide
193204, Sonthalia, Sidharth, et al
In this study, we demonstrate that UA-induced cardiomyocyte injury is associated with cytoplasmic lipid deposition, which can be ameliorated by the FA metabolism-promoting drug L-carnitine (LC)
Protein oxidation and aging
This option appeals to individuals who prefer the convenience of fewer doses, as it requires only one injection per week rather than daily administration
Yes, older adults, those taking diuretic medications, people with kidney disease, and individuals with physically demanding jobs or who exercise intensely may have increased risk